Skip to main content
Caplight Logo









Orixha

Orixha

Private
Maisons-AlfortHealthcare & Life Scienceshttps://orixha.com/

Last Round

Grant

May 20, 2025

Total Funding Raised

$16.17M

Company Overview

Orixha is a medical technology company that develops a proprietary total liquid ventilation technology to improve clinical outcomes for critical care patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

total liquid ventilationTLVtherapeutic hypothermiacritical care medical devicecardiac arrest treatmentmedical techmedtechrespiratory supportorgan protectionrazor and blade modelconsumable medical suppliesdeeptech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orixha Comparables

Compare Orixha with similar companies based on industry and business-model similarity.

Orixha comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EM-MED Sp. z o.o. Sp. K.
79%
BrainCool AB
78%
Life Recovery Systems
76%

Orixha Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 20, 2025
SeedApr 10, 2024
GrantOct 1, 2022
SeedDec 10, 2021
GrantJun 2, 2020

Key People

Founding team and executive leadership

Mathieu Nadeau

CTO & Co-Founder

Founding Team

Renaud Tissier

Co-founder - Acting CMO

Founding Team

Fabrice PAUBLANT

CEO co-founder

Founding Team

Orixha Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors increased 86% MoM, reaching 1.4K.

  • Feb 3, 2026

    Grew 40% QoQ from 10 to 14 employees.

Orixha Filings

Explore SEC and related filing metadata, where available.

Orixha filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Orixha's valuation, stock price, and market status.

Is Orixha a public or private company?

Orixha is a private company.

What is the current stock price of Orixha?

Orixha is a private company with no public stock price. No recent secondary market data is available.

How much is Orixha worth (valuation)?

Valuation information for Orixha is not publicly available.

Can I buy Orixha stock?

Orixha shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Orixha's last funding round?

Funding round information for Orixha is not publicly available.

Who are the main investors in Orixha?

Investor information for Orixha is not publicly disclosed.

Will Orixha IPO soon?

No public IPO plans have been announced for Orixha.

How can I track Orixha secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orixha's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMaisons-Alfort
Employee Range12
Year Founded2018
Last FundingMay 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?